اکثر مکاتبات کومش از طریق ایمیل سایت می باشد. لطفا Spam ایمیل خود را نیز چک نمایید.
   [Home ] [Archive]   [ فارسی ]  
:: ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
Subscription::
Contact us::
Site Facilities::
Webmail::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 24, Issue 1 (بهمن و اسفند 1400) ::
Koomesh 1400, 24(1): 26-37 Back to browse issues page
Review on Interferon beta: from cells to clinical usage
Fatemeh Hajilou , Pouya Youeseflee , Mehrnoosh Pashaei , Kimiya Bagheri , Bahador Bagheri
Abstract:   (2051 Views)
Introduction: Interferon (IFN) was first introduced by Isaacs and Linddeman in 1957. It referred to a factor that could cause inhibition in the growth of the live influenza virus. Interferons are intracellular proteins that are involved in many cellular processes such as growth, proliferation, differentiation, metabolism of the extracellular matrix, apoptosis, and regulating immune responses. There are different intereferones. Amog them, interferons-beta (IFN-β) is a natural cytokine produced by immune cells in response to biological and chemical stimuli. Signal transduction of IFN-β is initiated throughout a heterodimeric receptor complex that is composed of IFNAR1 and IFNAR2 which leads to expression of various proteins via the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway as well as other pathways. In addition to antiviral effects of IFN-β, it has been shown to have therapeutic effects in some autoimmune diseases such as multiple sclerosis, rheumatoid arthritis and lupus. It has recently been shown that the use of IFN-β in combination with other antiviral compounds may be effective in treatment of Covid-19. In this review the various topics about IFN-β are investigated such as signalling pathways, biological functions, therapeutic effects, and side effects of IFN-β therapy.  
Keywords: Interferon-beta, Signal Transduction, Therapeutic Uses, COVID-19, SARS-CoV-2, Autoimmune Diseases, biological functions, therapeutic effects, side effects
Full-Text [PDF 1182 kb]   (529 Downloads)    
Type of Study: Review | Subject: review
Received: 2021/02/28 | Accepted: 2021/08/29 | Published: 2022/01/20
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hajilou F, Youeseflee P, Pashaei M, Bagheri K, Bagheri B. Review on Interferon beta: from cells to clinical usage. Koomesh 1400; 24 (1) :26-37
URL: http://koomeshjournal.semums.ac.ir/article-1-6937-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 1 (بهمن و اسفند 1400) Back to browse issues page
کومش Koomesh
Persian site map - English site map - Created in 0.08 seconds with 38 queries by YEKTAWEB 4645